EXOMEGA EMOLLIENT

Main information

  • Trade name:
  • EXOMEGA EMOLLIENT 100ML LOT
  • Dosage:
  • 1.0,0.35,0.30,0.15;%W/W
  • Pharmaceutical form:
  • LOT
  • Composition:
  • 100ML
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EXOMEGA EMOLLIENT 100ML LOT
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

17-5-2017

Orphan designation:  3-[5-(2-Fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid,  for the: Treatment of cystic fibrosis

Orphan designation: 3-[5-(2-Fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid, for the: Treatment of cystic fibrosis

On 27 May 2005, orphan designation (EU/3/05/277) was granted by the European Commission to The Matthews consultancy Ltd, UK, for 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid for the treatment of cystic fibrosis.

Europe - EMA - European Medicines Agency

21-3-2018

EU/3/14/1363 (Quintiles Ireland Limited)

EU/3/14/1363 (Quintiles Ireland Limited)

EU/3/14/1363 (Active substance: 4-[[(1S,4S)-5-[[4-[4-(oxazol-2-yl)phenoxy]phenyl]methyl]-2,5-diazabicyclo[2.2.1]hept-2-yl]methyl]benzoic acid) - Transfer of orphan designation - Commission Decision (2018)1818 of Wed, 21 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/131/14/T/01

Europe -DG Health and Food Safety

19-12-2017

BENZOICUM ACIDUM (Benzoic Acid) Liquid [Washington Homeopathic Products]

BENZOICUM ACIDUM (Benzoic Acid) Liquid [Washington Homeopathic Products]

Updated Date: Dec 19, 2017 EST

US - DailyMed